Copy of News & Events | K36tx

top of page

Latest News

August 5, 2025

K36 Celebrates Scientific Founder Dr. Or Gozani's Publication in Nature Elucidating NSD2's Critical Role in Oncogenesis and Epigenetic Regulation

August 5, 2025

K36 Celebrates Scientific Founder Dr. Or Gozani's Publication in Nature Elucidating NSD2's Critical Role in Oncogenesis and Epigenetic Regulation

NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers | Nature

July 2025

Executive Director Chad Lewis Leads K36 Team in Publishing Critical NSD2 Research in Journal of Biological Chemistry

Characterization of the activity of KTX-1001, a small molecule inhibitor of multiple myeloma SET domain using surface plasmon resonance

December 2024

K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 66th American Society of Hematology (ASH) Annual Meeting

Multiple posters to be presented

View Older Posts

Media Contact
info@k36tx.com

bottom of page